Artemether-lumefantrine | Â |
Patients weighing: | Â |
 5–14 kg received 1 tablet, |  |
 15–24 kg received 2 tablets, |  |
 25–34 kg received 3 tablets, |  |
 > 34 kg received 4 tablets at presentation (0 h), 8 h later and at 24, 36, 48 and 60 h after the first dose. |  |
Artesunate-amodiaquine | Â |
Patients weighing: | Â |
  ≥ 4.5 – < 9 kg received 1 tablet of 25 mg/67.5 mg formulation |  |
  ≥ 9 – < 18 kg received 1 tablet of 50 mg/135 mg formulation |  |
  ≥ 18 – < 24 kg received 1 tablet of 100 mg/270 mg formulation |  |
 24–36 kg received 1.5 tablet of 100 mg/270 mg formulation |  |
 > 36 kg received 2 tablets of 100/270 mg formulation daily for 3 days. |  |
Dihydroartemisinin-piperaquine | Â |
Patients weighing: | Â |
  ≥4.5 – <10 kg received ¾ of 1 tablet |  |
 10 – <16 kg, received 1.5 tablet |  |
 16 – <24 kg, received 2 tablets |  |
 24 – <34 or received 2.5 tablets |  |
 34 – <50 kg received 3 tables daily for 3 days. |  |